英文名稱 | Tixagevimab (Synonyms: AZD8895) |
---|---|
中文名稱 | 替沙格韋單抗 |
CAS號 | 2420564-02-7 |
分子量 | 146.48 kDa |
外觀 | Colorless to light yellow liquid |
英文名稱 | Tixagevimab (Synonyms: AZD8895) |
---|---|
中文名稱 | 替沙格韋單抗 |
CAS號 | 2420564-02-7 |
分子量 | 146.48 kDa |
外觀 | Colorless to light yellow liquid |
Tixagevimab (AZD8895) is a human monoclonal antibody that targets the SARS-CoV-2 receptor binding domain (RBD). It exhibits neutralizing activity against SARS-CoV-2 by binding to the RBD and the S-glycoprotein ectodomain and blocking S-glycoprotein-mediated binding to the receptor.